about
The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alphaNovel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancer.Evolutionary strategy for systemic therapy of metastatic breast cancer: balancing response with suppression of resistanceDrug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.Efficacy and tolerability of high dose "ethinylestradiol" in post-menopausal advanced breast cancer patients heavily pre-treated with endocrine agents.Sequencing of hormonal therapy in breast cancer.Transcription-induced DNA double strand breaks: both oncogenic force and potential therapeutic target?First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?Targeting oestrogen to kill the cancer but not the patient.PKCα and ERβ Are Associated with Triple-Negative Breast Cancers in African American and Caucasian Patients.The pitfall of the transient, inconsistent anticancer capacity of antiestrogens and the mechanism of apparent antiestrogen resistanceSecond-line treatment of postmenopausal women with advanced breast carcinoma.Selective Human Estrogen Receptor Partial Agonists (ShERPAs) for Tamoxifen-Resistant Breast CancerInvolvement of estrogen-related receptors in transcriptional response to hypoxia and growth of solid tumors.Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study.Estradiol-induced regression in T47D:A18/PKCalpha tumors requires the estrogen receptor and interaction with the extracellular matrix.Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implicationsL-Type Calcium Channels Modulation by Estradiol.Endocrine Therapy in the Current Management of Postmenopausal Estrogen Receptor-Positive Metastatic Breast Cancer.Emerging drugs in metastatic breast cancerEndocrine therapy-resistant breast cancer model cells are inhibited by soybean glyceollin I through Eleanor non-coding RNAThe Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology
P2860
Q28237115-72A2B594-B044-459B-B781-B09AAF69CB5FQ34458253-C25FFA19-84B0-4B20-9112-860FA4CB42CDQ34650211-036750B5-0085-4949-A997-24BDB864CCB3Q34658267-6BDFF55E-90FF-4C28-ABD2-40DE7AD2959EQ34944679-42D793F2-A572-4A52-8CD9-D786F4A154A4Q34975951-CC23AF08-A8D2-4C10-B16B-B4B5DD9AA193Q35053261-C034ADD4-A9FA-421F-8FAD-BEB324C15ACAQ35622444-912C8934-A1B8-4EDA-B97C-66DB46403AFAQ35680855-840F1498-9C56-4E92-9E21-4100233EB76DQ35821415-5AB387AE-89DF-43ED-BA0B-0B4AC26C26B5Q35939435-03A03A49-3380-47E6-B162-3FB44E69C096Q36448699-D8F4CE08-813A-4841-BF91-13775EFD13ECQ36656704-12185722-8065-481B-B731-58CE2985697FQ36693861-EB6FC1BA-B3FA-401A-B386-C8EC85DF1092Q36778032-66E2494A-D3BE-40C3-A99A-E284C0E6E372Q37182310-CCF4BB8D-9F1A-4DD4-824E-81703C6F6A45Q37346786-7CC31F0F-B95A-49F8-96E9-53B6A6FC7C2BQ37525906-350DFF2B-44E9-46BC-8E5F-77211BADE6D9Q38831286-598B9D9C-40B7-4D10-8115-8FC3A05F72B2Q39185424-E5E52C81-C1BA-44CE-8808-6C8FDFE4C103Q57142532-3E26C292-D9BC-4847-B790-0E5C36A3D4D9Q57472758-A0994B9A-EEDA-4177-8B3C-67113A5010A8Q58707374-C2058E83-8278-46B6-A50A-905B81B33E91
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Estrogen as therapy for breast cancer
@nl
Estrogen as therapy for breast cancer.
@ast
Estrogen as therapy for breast cancer.
@en
type
label
Estrogen as therapy for breast cancer
@nl
Estrogen as therapy for breast cancer.
@ast
Estrogen as therapy for breast cancer.
@en
prefLabel
Estrogen as therapy for breast cancer
@nl
Estrogen as therapy for breast cancer.
@ast
Estrogen as therapy for breast cancer.
@en
P2860
P356
P1476
Estrogen as therapy for breast cancer.
@en
P2093
James N Ingle
P2860
P2888
P304
P356
10.1186/BCR436
P407
P577
2002-05-15T00:00:00Z
P5875
P6179
1010302564